Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 3, 2004

View Archived Issues

Phase II study evaluates IDN-6556 in HCV patients

Anadys and Roche enter new drug discovery collaboration

New SGLT modulators identified at Aventis

Merck presents novel 11beta-HSD1 inhibitors for diabetes therapy

Wyeth scientists isolate novel antibiotics from Acremonium sp.

New GPR-88 inhibitors and their use in depression, rhythm disorders, etc.

New antibacterial triazines under study at Hamari Chemicals

Ono researchers identify new chemokine CXCR4 modulators

JNK inhibitors for cardiovascular disorders claimed by Takeda

Autoantibody based peptide improves lupus in vivo

Uridine prodrug shows beneficial effects in models of Alzheimer's disease, hypoxia, oxidative stress

Vaccination against ghrelin reduces food intake in mice

Toll-like receptor 4 antagonist promising against IBD in mice

Effects of nalmefene on food intake and body weight of diet-induced obese mice

Small peptide shows potential prophylactic effects against malaria

Extension of indication recommended for Arixtra, Quixidar

Positive European opinion for use of Enbrel in psoriasis

European CHMP recommends approval of Remicade for psoriatic arthritis

Positive opinion in E.U. for Mimpara

European approval recommended for Emselex

CHMP completes safety review of SonoVue

Campral receives FDA approval

Completion of MDS Proteomics reorganization

Results of trials evaluating high-dose Aggrastat in high-risk patients

Louisiana State University and Bionomics enter cancer gene therapy agreement

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...